Search

The validation of systems (here: computer-aided systems, IT systems) ensures that they function as described in practice. Valida - tion is mandatory, especially when used in blood donation or in the GxP environment in general. If a donation is tested as HIVpositive, the system must reliably prevent it from being placed on the market. Validation is a test and part of the risk management. [ABSTRACT FROM AUTHOR]

Why you should read this article: • To understand the traumatic effects of suicide on families, friends and healthcare professionals • To enhance your awareness of the factors that affect suicide risk • To support you to risk assess and manage patients who present with self-harm Suicide is a tragic event that has traumatic and far-reaching effects on families, friends and healthcare professionals, for whom feelings of guilt, blame and regret are common. Although there have been reductions in suicide rates globally and in the UK over past decades, it remains one of the leading causes of death. Assessing and supporting people who present with self-harm and risk of suicide are essential aspects of all nurses' clinical practice. This article explains the relationship between suicide, self-harm and other risk factors. It also provides guidance for general nurses on evidence-based approaches to managing self-harm and assessing suicide risk collaboratively with service users. [ABSTRACT FROM AUTHOR]

Adverse drug reactions (ADRs) are increasingly common and are a significant cause of morbidity and mortality. Historically, ADRs have been classified as type A or type B. Type A reactions are predictable from the known pharmacology of a drug and are associated with high morbidity and low mortality. Type B reactions are idiosyncratic, bizarre or novel responses that cannot be predicted from the known pharmacology of a drug and are associated with low morbidity and high mortality. Not all ADRs fit into type A and type B categories; therefore, additional categories have been developed. These include type C (continuing), type D (delayed use), and type E (end of use) reactions. Susceptibility to ADRs is influenced by age, gender, disease states, pregnancy, ethnicity and polypharmacy. Drug safety is reliant on nurses and other healthcare professionals being alert to the possibility of ADRs, working with patients to optimise medicine use and exercising vigilance in the reporting of ADRs through the Yellow Card Scheme. [ABSTRACT FROM AUTHOR]

Risk management for people with dementia has traditionally focused on preventing physical harm. However, research has demonstrated that focusing on the physical safety of people with dementia may result in their social and psychological wellbeing being overlooked-the very aspects that are necessary to achieve person-centred care. This article discusses the main challenges for practitioners caring for people with dementia in various settings, and encourages a care approach which enables appropriate risk taking as a way of promoting person-centred care. [ABSTRACT FROM AUTHOR]

This article focuses on how to undertake peripheral cannulation by providing the theoretical basis for understanding the anatomy of veins, how to improve venous access and choosing a suitable vein and device. It also provides a practical guide of how to insert a cannula safely as well as prevention and management of complications during and following insertion. [ABSTRACT FROM AUTHOR]

This article proposes that cognitive behavioural therapy - as recommended by the National Collaborating Centre for Mental Health (2002) - can be used to form part of a risk management strategy for people diagnosed with schizophrenia. This may be a more effective and acceptable intervention because of its collaborative nature. The article includes case studies from practice to illustrate strategies that can be used. [ABSTRACT FROM AUTHOR]

This article is the last in this series based on the Seven Steps to Patient Safety. Each article analyses one of the seven steps and offers a resource for healthcare staff to enhance knowledge, skills and attitudes relating to patient safety. This article identifies solutions and actions that healthcare staff can take to improve patient safety. [ABSTRACT FROM AUTHOR]

This is the second in a series of seven articles on the National Patient Safety Agency's Seven Steps to Patient Safety (NPSA 2004a). Leadership and support for staff can be achieved by ensuring that patient safety has a clear focus throughout the organisation. This article considers the context in which nurses work and provides examples of what can be done at organisational, directorate and team levels to ensure patient safety. [ABSTRACT FROM AUTHOR]

This is the first article in a series of seven based on the Seven Steps to Patient Safety (National Patient Safety Agency (NPSA) 2004a). It is aimed at enhancing nurses' and midwives' knowledge about patient safety, including strategies and tools that are available to improve the quality of health care. This article outlines the patient safety agenda and emphasises the importance of creating an open and fair culture in the NHS. [ABSTRACT FROM AUTHOR]

Provides an overview of the results from the second year of the Royal College of Nursing's Be Sharp Be Safe sharps injuries surveillance project in Great Britain and indicates how the data can be used to help improve practice. Extent of the problem of sharps injuries in the National Health Service; Activities which gave rise to a considerable proportion of the injuries reported; Locations in which the larges number of injuries occurred.

The aim of this article, the third in this series on the Seven Steps to Patient Safety (National Patient Safety Agency (NPSA) 2004), is to explore how risk management can be integrated into the culture of a healthcare organisation and the working practices of clinicians, managers and their immediate teams. [ABSTRACT FROM AUTHOR]

The article describes the risk management approach of Irvine, Texas-based engineering and construction firm Fluor Corp. Topics covered include the old idea on how the company practices risk management that was dispelled by Paul Bruno, Fluor's managing general counsel, the financial performance of the company in 2014 and the reasons monetizing personal injury risk should be avoided at all costs according to Bruno.

On most industrial projects, the baseline schedule completion date and the indicated schedule completion date are typically the same, unless the schedule is forcibly re-baselined. Key learnings have indicated that a reevaluation of the scope, schedule and budget is essential. [ABSTRACT FROM AUTHOR]

The article discusses the use of four dimensional (4D) Building Information Modeling (BIM) tools for delay claims, as they help illustrate what really happened on a project but require work to pull together. It discusses the limitations of 4D BIM with delay analysis including some visualization and analysis techniques not yet fully automated in off-the-shelf 4D modeling software, requiring manual performance, and proportion of 4D BIM investment cost to how much is in dispute or at risk.